Tyler CVC - Cardiovascular Consultants
Tyler CVC - Cardiovascular Consultants: About Us
Tyler CVC - Cardiovascular Consultants: Our Team
Tyler CVC - Cardiovascular Consultants: Conditions & Treatment
Tyler CVC - Cardiovascular Consultants: Patient Information
Tyler CVC - Cardiovascular Consultants: Locations and Affiliations
Tyler CVC - Cardiovascular Consultants: Contact Us
Tyler CVC - Cardiovascular Consultants: Employment Opportunities
Tyler CVC - Cardiovascular Consultants
Tyler CVC - Cardiovascular Consultants
Tyler CVC - Cardiovascular Consultants: What's New at Tyler
Tyler CVC - Cardiovascular Consultants
Call 800 543-2783 to schedule your appointment TODAY!
619 S. Fleishel · Tyler, Texas 75701 · Phone: 903-595-5514 · Toll-Free: 800-543-2783
Tyler CVC - Cardiovascular Consultants: Our Team

J. Daniel Jackman, M.D., F.A.C.C. - Publications

  • Weingarten JS, Huang DY, Jackman JD. Rhodococcus equi pneumonia: an unusual early manifestation of the acquired immunodeficiency syndrome. Chest 1988;94:195-6
  • McBride W, Jackman JD. High-output cardi. failure in patients w/mult myeloma. N Eng Jrl Med 1988;319:1651-3
  • Jackman JD, Radolf JD. Cardiovascular syphilis. Am J Med 1989;87:425-33
  • Leporrier M, Jackman JD. High-output cardi. failure/mult myeloma. N Eng J Md 1989;320:1419-20
  • McBride W, Jackman JD, Grayburn PA. Prevalence & clinical characteristics of a high cardiac output state in patients with multiple myeloma. Am J Med 1990;89:21-4
  • Tcheng JE, Jackman JD, Gardner LH. Optimization of long-term outcome in acute mitral regurgitation due to myocardial infarction. Circulation 1990;82(suppl III): 111-511 (abstract)
  • Jackman JD, Glamann DB. Gonococcal endocarditis: 25 yrs exp. Am J Med Sci 1991;301:221-30
  • Jackman JD, Tcheng J, Stack R. Current concepts in mgmnt/ischemic mitral regurgitation Card. 1991;4:76
  • Jackman JD, Navetta FI, Stack RS. Percutaneous transluminal coronary angioplasty in octogenarians as an effective therapy for angina pectoris. Am J Cardiol 1991;68:116-9
  • Jackman JD, Croll MA, Phillips HR. "Hugging balloons" through sngl 8-french guide:salvage angiolst. w/lytic therapy in the infarct vessel of 40-yr-old man. Cath Card Diag 1991;24:45-50
  • Jackman JD, Simonsen R. The clinical manifestations of cardiac mucormycosis. Chest 1992;101:1733-6
  • Jackman JD, Hermiller JB, Sketch MH. Combined rotational and directional atherectomy guided by intravascular ultrasound in an occluded vein graft. Am Heart J 1992;124:214-6
  • Jackman JD, Zidar JP, Tcheng JE. Outcome following prolonged balloon inflations of over 20 minutes after unsuccessful coronary angioplasty. J Am Coll Cardiol 1992;19(supA):351A (abst).
  • Zidar JP, Tenaglia AN, Jackman JD. Improved acute results for PTCA of long lesions using long angioplasty balloon catheters. J Am Coll Cardiol 1992;19(supplA): 34A (abstract)
  • Tcheng JE, Jackman JD, Nelson CL. Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intern Med 1992;117:18-24
  • Krucoff MW, Jackman JD, Crater S. "Over the shoulder" guidewire manipulation through an angulated stenosis adjacent to a coronary aneurysm during high risk percutaneous transluminal angioplasty. J Intervent Cardiol 1992'323-30
  • Culp SC, Chapman GD, Jackman JD. Perfusion balloon angioplasty: In-vivo comparison of catheters with different rates of flow. Clin Res 40:257A, 1992 abstract
  • Jackman JD, Zidar JP, Tcheng JE. Outcome following prolonged balloon inflt. of 20 minutes for initially unsuccessful percutaneous transluminal coronary angioplasty. Am J Cardiol 1992;69:1417 21
  • Zidar JP, Jackman JD, Gammon RS. Serial assessment of heparin coat. on vascular responses to a new tantalum stent. Circulation 1992;86 (suppl 1) 1-185 (abstract)
  • Zidar J, Jackman JD. Long term angiograpic & histopathologic results of new tantalum stent Cir.1992;86:1-732
  • Zidar JP, Jackman JD, Tenaglia AN. Late outcome for PTCA of long coronary lesions using long angioplasty balloon catheters. Circulation 1992;86(suppl 1):1-512 (abstract
  • Culp SC, Zidar JP, Jackman JD. Improved rabbit model of atherosclerosis. Cir 1992; 86A (sl):1-188(A)
  • Culp SC, Zidar JP, Jackman JD. Thermal-perfusion balloon angioplasty: Thermal dosing studies in an in-vivo atherosclerotic rabbit model. Circulation 1992; 86 (suppl 1):1-733 (abstract)
  • Tcheng JE, Bittl JA, Jackman JD. Treatment of aorto-ostial disease with percutaneous excimer laser coronary angioplasty. Circulation 1992;86 (suppl 1):1-512 (abstract)
  • Zidar JP, Virmani R, Jackman JD. Quantitative histopatholigic analysis of the vascular response heparin coating of the Cordis stent. J Am Coll Cardio 1993;21 (suppl A):336A (abstract)
  • Tenaglia AN, Jackman JD. Treatment of long coronary artery narrowings w/long angioplasty balloon catheters. Am J Cardio 1993;71:1274-7.
  • Tcheng JE, Jackman JD, Nelson CL. Does reperfusion improve prognosis when mitral regurgitation complicates infarction. Cardiology Board Review 1993;10:17-33
  • Tcheng J, Jackman JD, Califf R. Managing myocardial infarction complicated by mitral regurgitation. Primary Cardiology 1993;19:40-8
  • Muhlestein JB, Zidar JP, Jackman JD. The vascular biology of Intrvt. Card. Med.-P&P 94; 119-32
  • Jollis JG, Jackman JD, Dean L. Percutaneous transluminal coronary angioplasty in the elderly: Interventional Cardiovascular Medicine - Principles and Practice 1994; 343-53
  • Zidar JP, Jackman JD, Labinaz M. Dissection, abrupt closure, and perforation. Interventional Cardiovascular Medicine - Principles and Practice 1994;601-16
  • Zidar JP, Labinaz M, Jackman JD. Biodegradable stents. Interventional Cardiovascular Medicine Principles & Practice 1994;921-31
  • Topol ER, Lincoff AM, Jackman JD, et.al. Bivalirudin and Provisional Glyoprotein IIb/IIIa Blockade compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention. JAMA February 19, 2003-Vol 289, No. 7:853-863
  • Lincoff AM, Bittl JA, Harrington RA, Jackman JD, et al. Long-term Efficacy of Bivalirudin and Privisional Glycoprotein IIb/IIIa Blockade vs Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Revascularization. JAMA August 11, 2004-Vol 292, No. 6:696-703
  • Cohen DJ, Lincoff AM, Lavelle TA, Huei-Ling Chen, Bakhai A, Berezin RH, Jackman JD, Sarembock MB, Topol EJ. Economic Evaluation of Bivalirudin With Provisional Glycoprotein IIb/IIIa Inhibition Versus Heparin With Routine Glycoprotein IIb/IIIa Inhibition for Percutaneous Coronary Intervention. JAMA November 9, 2004 - Vol. 44, pp. 1792-1800.
 
 
About Us | Our Team | Conditions & Treatments | Patient Information | Locations | Contact Us | Home
 

Copyright ©2008 Tyler Cardiovascular Consultants, PA
619 S. Fleishel • Tyler, Texas 75701 • 903-595-5514 • Toll-Free: 800-543-2783 • info@tylercvc.com

 

Medical Websites by HealthPresence